FDA Grants Accelerated Approval For Biogen's ALS Drug
26/4 03:40
(RTTNews) - Biogen Inc. (BIIB) said that the U.S. Food and Drug Administration has approved Qalsody (tofersen) 100 mg/15mL injection for the treatment of amyotrophic lateral sclerosis or ALS in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene....